Vident Investment Advisory, LLC Eagle Pharmaceuticals, Inc. Transaction History

Vident Investment Advisory, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$38.66 - $51.82 $746,679 - $1 Million	-19,314 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $99,511 - $183,548	-2,710 Reduced 12.3%	19,314 $778,000
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $1.47 Million - $1.85 Million	22,024 New	22,024 $1.53 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.